Page 166 - Read Online
P. 166

Author Instructions

           can replicate the work.
           Authors should provide raw data if referees and the Editors of CDR request.
           Simultaneous submission of manuscripts to more than one journal is not tolerated.
           Republishing content that is not novel is not tolerated (for example, an English translation of a paper that is already
           published in another language will not be accepted).
           The manuscript should not contain any information that has already been published. If you include already published
           figures or images, please get the necessary permission from the copyright holder to publish under the CC-BY license.
           Plagiarism, data fabrication and image manipulation are not tolerated.
           Plagiarism is not acceptable in CDR.
           Plagiarism involves the inclusion of large sections of unaltered or minimally altered text from an existing source without
           appropriate and unambiguous attribution, and/or an attempt to misattribute original authorship regarding ideas or results,
           and copying text, images, or data from another source, even from your own publications, without giving credit to the
           source.
           As to reusing the text that is copied from another source, it must be between quotation marks and the source must be
           cited. If a study’s design or the manuscript’s structure or language has been inspired by previous studies, these studies
           must be cited explicitly.
           If plagiarism is detected during the peer-review process, the manuscript will be rejected. If plagiarism is detected after
           publication, we will publish a retraction and retract the paper.
           If plagiarism is detected during the peer-review process, the manuscript may be rejected. If plagiarism is detected after
           publication, we may publish a Correction or retract the paper.
           Falsification is manipulating research materials, equipment, or processes, or changing or omitting data or results so that
           the findings are not accurately represented in the research record.
           Image files must not be manipulated or adjusted in any way that could lead to misinterpretation of the information
           provided by the original image.
           Irregular manipulation includes: introduction, enhancement, moving, or removing features from the original image;
           grouping of images that should be presented separately, or modifying the contrast, brightness, or color balance to obscure,
           eliminate, or enhance some information.
           If irregular image manipulation is identified and confirmed during the peer-review process, we will reject the manuscript.
           If irregular image manipulation is identified and confirmed after publication, we may publish a Retraction or retract the
           paper.
           CDR reserves the right to contact the authors’ institution(s) to investigate possible publication misconduct if the Editors
           find conclusive evidence of misconduct before or after publication. OAE has a partnership with iThenticate, which
           is the most trusted similarity checker. It is used to analyze received manuscripts to avoid plagiarism to the greatest
           extent possible. When plagiarism becomes evident after publication, we will retract the original publication or require
           modifications, depending on the degree of plagiarism, context within the published article, and its impact on the overall
           integrity of the published study. Journal Editors will act under the relevant COPE Guidelines.
           4. Authorship
           Authorship credit of CDR journals should be solely based on substantial contributions to a published study, as specified in
           the following four criteria:
           1. Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data
           for the work;
           2. Drafting the work or revising it critically for important intellectual content;
           3. Final approval of the version to be published;
           4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity
           of any part of the work are appropriately investigated and resolved.
           All those who meet these criteria should be identified as authors. Authors must specify their contributions in the section
           Authors’ Contributions of their manuscripts. Contributors who do not meet all the four criteria (like only involved in
           acquisition of funding, general supervision of a research group, general administrative support, writing assistance,
           technical editing, language editing, proofreading, etc.) should be acknowledged in the section of Acknowledgement in the
           manuscript rather than being listed as authors.
           If a large multiple-author group has conducted the work, the group ideally should decide who will be authors before the
           work starts and confirm authors before submission. All authors of the group named as authors must meet all the four
           criteria for authorship.

           5. Reviewers Exclusions
           You are welcome to exclude a limited number of researchers as potential editors or reviewers of your manuscript. To
           ensure a fair and rigorous peer review process, we ask that you keep your exclusions to a maximum of three people. If you
           wish to exclude additional referees, please explain or justify your concerns—this information will be helpful for editors
           when deciding whether to honor your request.

                      Cancer Drug Resistance                                                             XIV
   161   162   163   164   165   166   167   168   169